Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support

Deborah Gleeson, James Scheibner, Dianne Nicol

Research output: Contribution to journalLetterpeer-review

2 Citations (Scopus)
4 Downloads (Pure)

Abstract

[Reply: Gleeson, D., Scheibner, J. and Nicol, D. (2023), Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support. Med J Aust, 219: 46-48. https://doi.org/10.5694/mja2.51990]

In reply: We thank Cueni and de Somer1 for their interest in our article.2 Equitable access to pandemic countermeasures is vital. What the world needs to ensure equity, however, is not privately held intellectual property (IP), but decentralised manufacturing underpinned by systematic technology transfer to manufacturers in low and middle-income countries.3
Original languageEnglish
Pages (from-to)439
Number of pages1
JournalMedical Journal of Australia
Volume219
Issue number9
Early online date16 Oct 2023
DOIs
Publication statusPublished - Nov 2023

Keywords

  • COVID-19
  • Global health
  • Health policy
  • Intellectual property
  • Pharmaceuticals
  • Public health
  • World Health Organization

Fingerprint

Dive into the research topics of 'Proposals to waive intellectual property rights for pandemic response products in the World Health Organization pandemic accord need Australia's support'. Together they form a unique fingerprint.

Cite this